Home
Glenmark Pharmaceuticals Limited
Press Release Oct 19 2020
Published Oct 19 2020
5 min read

Press Release Oct 19 2020

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 19, 2020, titled "Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg".

View Attachment